Related by context. All words. (Click for frequent words.) 76 anticoagulation therapy 73 oral anticoagulation 72 beta blocker therapy 72 anticoagulation 71 antithrombotic therapy 71 anticoagulant therapy 71 lipid lowering therapy 69 bisphosphonate therapy 69 thromboprophylaxis 69 thrombolytic therapy 69 coronary revascularization 68 NATRECOR R 68 thrombolytic agents 68 statin therapy 67 tamoxifen therapy 67 androgen suppression 67 antidepressant therapy 67 NSAID therapy 67 antiplatelet medication 67 β blockers 67 antiplatelet therapy 67 glucocorticoid therapy 66 reperfusion therapy 66 postoperative mortality 66 antiarrhythmic drug 66 corticosteroid therapy 66 androgen deprivation 66 revascularization procedures 66 dual antiplatelet therapy 66 antiarrhythmic drugs 66 eptifibatide 66 EXJADE 66 pelvic lymphadenectomy 66 ICD therapy 66 antihypertensive therapy 66 ICD implantation 66 warfarin anticoagulation 65 aspirin regimen 65 GnRH agonists 65 chemoradiotherapy 65 warfarin 65 FROVA 65 rFVIIa 65 systemic corticosteroids 65 nonpharmacologic 65 cytotoxic chemotherapy 65 perioperatively 65 thromboembolic events 65 resynchronization therapy 65 chemoradiation therapy 65 loop diuretics 64 perioperative mortality 64 VTE prophylaxis 64 lung resection 64 OPCAB 64 preoperative chemotherapy 64 APTIVUS r 64 antibiotic prophylaxis 64 antiplatelet drugs 64 carotid artery stenting 64 anticlotting drugs 64 fibrinolytic therapy 64 Hydroxyurea 64 levodopa therapy 64 upper gastrointestinal bleeding 64 antimicrobial prophylaxis 64 DAPT 64 paroxysmal AF 64 bypass grafting 64 oral anticoagulants 64 antiplatelet therapies 64 DMARD therapy 64 antidiabetic drugs 64 testosterone supplementation 64 lymph node dissection 64 dopaminergic therapy 64 postoperative AF 64 oral anticoagulant therapy 64 thrombotic complications 64 serum phosphorous 64 immunosuppressive regimen 64 carotid revascularization 64 COREG 64 subclinical hypothyroidism 63 adjuvant radiotherapy 63 anthracycline therapy 63 renal dysfunction 63 androgen ablation 63 elective PCI 63 alteplase 63 intravenous diuretics 63 perioperative morbidity 63 intensive statin therapy 63 antihypertensive medication 63 tissue plasminogen activator tPA 63 MULTAQ 63 thromboembolic 63 systemic corticosteroid 63 oral antidiabetic medication 63 carotid endarterectomy 63 therapeutic regimens 63 PRADAXA 63 conventional angiography 63 atrioventricular block 63 symptomatic VTE 63 postoperative morbidity 63 carotid stenosis 63 chemoradiation 63 clinically localized prostate 63 antihypertensive medications 63 decompensated heart failure 63 patients undergoing CABG 63 coronary arteriography 63 dose Iluvien 63 trials RCTs 63 intravenous bisphosphonates 63 salmeterol fluticasone 63 adjuvant therapies 63 oncologic outcomes 63 catheter angiography 63 immunosuppressive therapies 63 reinfarction 63 coronary revascularization procedures 63 clopidogrel therapy 63 comorbid conditions 63 PREZISTA r 63 platelet inhibition 63 coronary angiography 63 recurrent VTE 63 NATRECOR ® 63 dose titration 63 immunomodulatory therapy 63 dosage regimens 63 Adjuvant chemotherapy 63 BYSTOLIC 63 adjuvant tamoxifen 63 FASLODEX 63 screening colonoscopy 63 UA NSTEMI 63 HSCT 63 radioiodine therapy 63 aldosterone antagonist 63 insulin detemir 63 noncardiac surgery 62 coronary interventions 62 revascularization procedure 62 aspirin therapy 62 Elitek 62 unfractionated heparin 62 artery stenosis 62 divalproex sodium 62 rt PA 62 AZOR 62 immunosuppressive medications 62 ablative therapy 62 stent placement 62 postoperative atrial fibrillation 62 chemotherapeutic regimens 62 ATACAND 62 APTIVUS 62 drug eluting stent implantation 62 cytoreductive surgery 62 colectomy 62 cilostazol 62 diagnostic workup 62 MADIT II 62 virologic failure 62 pretest probability 62 ARIXTRA 62 coronary stenting 62 BENICAR HCT 62 radical cystectomy 62 antithrombotic therapies 62 antiplatelet agents 62 glycated hemoglobin levels 62 eculizumab therapy 62 thoracoscopic lobectomy 62 thrombolysis 62 platelet reactivity 62 dose atorvastatin 62 acute STEMI 62 coronary intervention 62 carotid artery stenting CAS 62 antioxidant supplementation 62 liver resection 62 percutaneous intervention 62 oral corticosteroids 62 COPD exacerbation 62 hepatectomy 62 opioid analgesia 62 pyridostigmine 62 stable angina 62 bolus dose 62 concomitant medications 62 typical antipsychotics 62 carotid endarterectomy CEA 62 adenotonsillectomy 62 carotid artery stenosis 62 left ventricular dysfunction 62 NSTE ACS 62 proliferative retinopathy 62 fluvastatin 62 TMP SMX 62 clot dissolving drug 62 virological response 62 lipid lowering agents 62 invasive coronary angiography 62 dosage regimen 62 Lung transplantation 62 transurethral resection 62 hepatorenal syndrome 62 intravitreal injections 62 aspirin clopidogrel 62 ACTOplus met 62 inotropic 62 lymphadenectomy 62 anticoagulant warfarin 62 FAMPYRA 62 PFO closure 62 anti arrhythmic drugs 61 Carotid endarterectomy 61 severe aortic stenosis 61 liver transplant recipients 61 periprocedural 61 ximelagatran 61 GnRH agonist 61 lipid lowering medications 61 aldosterone antagonists 61 TAVR 61 immunosuppressive agents 61 clopidogrel Plavix 61 anti coagulant therapy 61 cytoreduction 61 postoperative complication 61 F FDG PET 61 LYSTEDA 61 biochemical recurrence 61 APTIVUS ritonavir 61 peginterferon 61 nesiritide 61 levosimendan 61 EFFEXOR XR 61 thromboembolic complications 61 clopidogrel pretreatment 61 warfarin dosage 61 chronic thromboembolic pulmonary 61 virological failure 61 antiviral therapy 61 radical nephrectomy 61 hemodialysis patients 61 riociguat 61 thrombus aspiration 61 postoperative pulmonary 61 adjuvant therapy 61 XELOX 61 STRIDE PD 61 gout flares 61 flutamide 61 pneumonectomy 61 docetaxel chemotherapy 61 VADT 61 postoperative radiotherapy 61 symptomatic hyponatremia 61 antidiabetic therapy 61 GP IIb IIIa inhibitors 61 AF ablation procedures 61 postoperative chemotherapy 61 QTc prolongation 61 interferon therapy 61 Mitoxantrone 61 unstable angina UA 61 sipuleucel T 61 colorectal liver metastases 61 phase IIb trial 61 antihypertensive drugs 61 Torisel 61 vaginal hysterectomy 61 paroxysmal atrial fibrillation 61 immunosuppressant therapy 61 endarterectomy 61 curative resection 61 lipid lowering medication 61 Insulin PH# 61 QTc interval 61 treprostinil 61 mycophenolate mofetil 61 ADHF 61 Coronary Artery Bypass Graft 61 immunosuppressive regimens 61 GP IIb IIIa inhibitor 61 recurrent venous thromboembolism 61 bronchial thermoplasty 61 anticoagulant medications 61 poor metabolizers 61 adalimumab 61 systolic hypertension 61 HAART regimen 61 leflunomide 61 myocardial ischemia 61 tirofiban 61 curative therapy 61 eplerenone 61 refractory angina 61 non squamous NSCLC 61 stratifying patients 61 paclitaxel eluting stents 61 FIRMAGON 61 TORISEL 61 lipid lowering drugs 61 figitumumab 61 nonmetastatic prostate cancer 61 hemoglobin A1c levels 61 calcineurin inhibitors 61 angiographic outcomes 61 cystectomy 61 androgen suppression therapy 60 inhaled corticosteroid therapy 60 revascularizations 60 hemorrhagic complications 60 pamidronate 60 cardiotoxicity 60 antiretroviral regimen 60 goserelin 60 sunitinib 60 aromatase inhibitor therapy 60 bowel resection 60 renal artery stenosis 60 analgesic medications 60 unfractionated heparin UFH 60 LMWH 60 decitabine 60 Zevalin consolidation 60 prostate cancer CaP 60 methotrexate therapy 60 ICD shocks 60 R0 resection 60 Octreolin 60 fondaparinux 60 Nesiritide 60 transthoracic 60 transcranial Doppler ultrasound 60 milrinone 60 MYCAMINE 60 Oral corticosteroids 60 adenoma recurrence 60 CMV disease 60 intravenous thrombolysis 60 romiplostim 60 TTF Therapy 60 undergoing CABG 60 ofpatients 60 Heavy menstrual bleeding 60 KAPIDEX 60 pulmonary artery banding 60 antithrombotic 60 antireflux surgery 60 coronary CTA 60 antidiabetic medication 60 thrombophilia 60 asymptomatic carotid stenosis 60 thrombocytopenic 60 COPD exacerbations 60 intravenous cyclophosphamide 60 atherothrombotic events 60 argatroban 60 INVEGA ® 60 paricalcitol 60 transcatheter closure 60 carotid stenting 60 biologic DMARD 60 atherogenic dyslipidemia 60 RRMS patients 60 statin 60 dose statin therapy 60 HbA1c levels 60 immunosuppressive medication 60 CTEPH 60 glycoprotein IIb IIIa inhibitors 60 bezafibrate 60 candesartan 60 recurrent ischemia 60 ischemic cardiomyopathy 60 nonfatal MI 60 myocardial revascularization 60 VIRAMUNE 60 systemic hypotension 60 thiazide diuretic 60 International Normalized Ratio 60 platelet inhibitor 60 IV NSCLC 60 PNH patients 60 antithrombotics 60 NPH insulin 60 cerebral angiography 60 urate lowering therapy 60 neoadjuvant chemotherapy 60 allopurinol 60 visilizumab 60 intracerebral haemorrhage 60 inhaled glucocorticoids 60 surgical revascularization 60 tecarfarin 60 revascularisation 60 DVT prophylaxis 60 EBRT 60 pacemaker implantation 60 cangrelor 60 atrial arrhythmias 60 sleeve lobectomy 60 LHRH agonists 60 myocardial reperfusion 60 angiotensin converting enzyme inhibitor 60 NIHSS score 60 parathyroidectomy 60 CHAMPION PCI 60 ablation procedures 60 hematologic toxicity 60 nonoperative 60 pCR 60 HAART regimens 60 ß blockers 60 Doxil ® 60 carotid stents 60 asthma exacerbation 60 sentinel lymph node biopsy 60 tumor resection 60 electrical cardioversion 60 hemodilution 60 Aprotinin 60 alpha blocker 60 intravenous tPA 60 revascularization 60 NNT = 60 pharmacologic treatments 60 ARCOXIA 60 acute ischemic stroke 60 renal biopsy 60 weekly subcutaneous injections 60 severe renal impairment 60 antiepileptic drugs AEDs 60 TNF antagonist 60 nonischemic 60 antibiotic regimens 60 5-FU/LV 60 certolizumab 60 venous thromboembolism prophylaxis 60 pharmacologic therapy 60 relapsed MM 60 DMARD 60 conventional antipsychotics 60 VIIBRYD 60 octreotide 60 glomerular filtration 60 cranial irradiation 60 placebo controlled trials 60 bronchodilator therapy 60 ALT flares 60 nonoperative treatment 60 pre operatively 60 chemoembolization 60 CsA 60 uric acid lowering 60 preserved ejection fraction 60 PICSO ® 60 angina pectoris 60 RLAI 60 pioglitazone HCl 60 thromboembolism 60 pimecrolimus 60 thrombolytics 60 serum calcium levels 60 adjuvant chemotherapy 59 preoperative evaluation 59 prognostic variables 59 BRCA testing 59 mRCC 59 decompressive surgery 59 CYPHER Stent 59 PRISTIQ 59 venous thromboembolic events 59 AGILECT R 59 unstable angina pectoris 59 venous thromboembolic disease 59 inotropes 59 postoperative complications 59 severe exacerbations 59 cardiac resynchronisation therapy 59 adjuvant radiation 59 DES implantation 59 intrathecal chemotherapy 59 antiepileptic medications 59 BANZEL 59 nephrotoxicity 59 TAXUS Stent 59 oral anticoagulant 59 Dabigatran 59 Mylotarg 59 LNG IUS 59 atherosclerotic renal artery stenosis 59 recurrent glioblastoma multiforme 59 nephrectomy 59 Coronary artery bypass grafting 59 Liver transplantation 59 conventional coronary angiography 59 pulmonary artery hypertension 59 antiplatelet medications 59 inhaled budesonide 59 metformin Glucophage 59 diagnostic modality 59 interferon ribavirin 59 cerebrovascular events 59 fragility fracture 59 intracranial stenosis 59 sustained virological response 59 adenoidectomy 59 direct thrombin inhibitors 59 EDSS scores 59 liver biopsies 59 Phase IIIb study 59 renoprotective 59 ribavirin therapy 59 clinical pharmacology studies 59 atorvastatin #mg 59 trastuzumab Herceptin ® 59 beta blocker 59 Carvedilol 59 oral antidiabetes 59 glatiramer acetate 59 acting insulin analogues 59 tenecteplase 59 everolimus eluting stents 59 atypical antipsychotic drugs 59 sustained virologic response 59 external beam radiotherapy 59 Natalizumab 59 Postoperative complications 59 FFR guided treatment 59 standard chemotherapy regimen 59 LOVENOX R 59 standard chemotherapy regimens 59 bevacizumab Avastin 59 defibrillator implant 59 preoperative radiotherapy 59 Abciximab 59 sotalol 59 nonfasting triglyceride levels 59 idraparinux 59 pharmacologic intervention 59 serum testosterone 59 cytoreductive nephrectomy 59 inhaled anticholinergics 59 angioplasty stenting 59 nonrandomized 59 estrogen progestin therapy 59 cardiac toxicity 59 tolterodine 59 CABG surgery 59 pharmacologic stress 59 anticoagulant medication 59 symptomatic aortic stenosis 59 indapamide 59 glargine 59 β blocker 59 chronic idiopathic thrombocytopenic purpura 59 FOLFOX4 59 oral rivaroxaban 59 vasomotor symptoms 59 ivabradine 59 reflux symptoms 59 oral NSAIDs 59 pimozide 59 SCIg 59 immunosuppression 59 IFN beta 59 PASI scores 59 rebleeding 59 carvedilol 59 post thrombotic syndrome 59 Corticosteroids 59 surrogate endpoint 59 MGd 59 hyperkalemia 59 transcranial Doppler 59 deferiprone 59 androgen deprivation therapy 59 AGHD 59 hydroxychloroquine 59 dexmedetomidine 59 D dimer 59 nephrotoxic drugs 59 IOP lowering 59 angiotensin receptor blockers 59 carotid artery blockage 59 intravesical therapy 59 dosing frequency 59 teriparatide 59 oral hypoglycemic agents 59 randomized controlled trials RCTs 59 XIENCE V PROMUS Stent 59 Hb A1C 59 verteporfin 59 tibolone 59 protease inhibitor PI 59 antihypertensive agents 59 canakinumab 59 clopidogrel 59 dacarbazine 59 Thrombolysis 59 axillary dissection 59 cinacalcet 59 inhaled steroids 59 irbesartan 59 morphometric vertebral fractures 59 antidiabetic medications 59 antifungal therapy 59 venous thromboembolism 59 occlusive disease 59 epidural analgesia 59 hyperglycaemia 59 mCRC patients 59 sorafenib Nexavar 59 transaminase levels 59 Carotid artery stenting 59 Carotid stenting 59 LVRS 59 laparoscopically assisted 59 AZILECT R 59 hyperbilirubinemia 59 doxorubicin docetaxel 59 clevidipine 59 ALND 59 debulking surgery 59 lomitapide 59 LATUDA 59 dose clopidogrel 59 Cardiopulmonary bypass 59 myocardial infarction MI 59 clot busters 59 lobectomy 59 genotypic resistance 59 inhaled nitric oxide 59 ICD implants 59 tiotropium 59 hepatic metastases 59 Lamictal XR 59 gastrointestinal bleeds 59 Kyphon Balloon Kyphoplasty 59 prophylactic therapy 59 reoperations 59 extubation 59 anticoagulants 59 adenomatous polyps 59 GAMMAGARD 59 antiepileptic drug 59 Vorapaxar 59 antibiotic therapy 59 risk stratification 59 clot busting therapy 59 antiangiogenic therapy 59 elevated CRP 59 palliative radiotherapy 59 abatacept 59 QTc 59 gefitinib Iressa 59 Dose escalation 59 lupus nephritis 59 Velcade bortezomib 59 cholinesterase inhibitor 59 adalimumab Humira 59 co morbidities 59 non valvular atrial 59 virologic response 59 postoperative bleeding 59 postprocedure 58 infliximab Remicade 58 IV tPA 58 renal transplantation 58 topical calcineurin inhibitors 58 axillary lymph node dissection 58 comorbidities 58 nonadherence 58 TAXUS Express Stent 58 cardioembolic stroke 58 thrombotic events 58 mesalamine granules 58 transcatheter aortic valve implantation 58 iron chelation therapy 58 hypertensives 58 dopamine partial agonist 58 Perforomist Inhalation Solution 58 thyroidectomy 58 Decitabine 58 RCTs 58 teriflunomide 58 posttransplant 58 subgroup analyzes 58 endometrial carcinoma 58 ABVD 58 symptomatic intracranial 58 randomized blinded 58 CIMZIA TM 58 CABG surgeries 58 Lantus insulin 58 antiarrhythmic medications 58 oral anticoagulation therapy 58 undergoing radical prostatectomy 58 laser photocoagulation 58 pegylated interferon alfa 2b 58 Allovectin 7 ® 58 Fibrillex TM 58 infarction STEMI 58 QVAR R 58 antiepileptics 58 atypical antipsychotic medications 58 fibrinolysis 58 dose colchicine 58 nicardipine 58 Navelbine ® 58 vinorelbine 58 recurrent DVT 58 chronic myocardial ischemia 58 CPAP therapy 58 WBPA 58 xanthine oxidase inhibitor 58 nadolol 58 tolvaptan 58 chemoprevention trials 58 inotropic therapy 58 STEMI ST 58 serum potassium levels 58 clomipramine 58 acute myocardial infarction AMI 58 cisplatin chemotherapy 58 otamixaban 58 CMV infection 58 symptomatic carotid stenosis 58 systolic dysfunction 58 endotracheal intubation 58 dose cytarabine 58 neurologic progression 58 Surgical resection 58 REVLIMID lenalidomide 58 efalizumab 58 QT prolongation 58 Ranolazine 58 Afib 58 pentoxifylline 58 RE LY 58 relapsing MS 58 dosing intervals 58 randomized controlled clinical trials 58 HoLEP 58 HbA 1c levels 58 phosphate binders 58 T2DM 58 myocardial infarctions 58 Degarelix 58 systemic immunosuppressive drugs 58 multivessel disease 58 hyperphenylalaninemia HPA due 58 moderate renal impairment 58 ZOMETA 58 ibandronate 58 urolithiasis 58 perioperative complications 58 invasive candidiasis 58 OSAHS 58 corticosteroid dose 58 epoetin beta 58 endometrial hyperplasia 58 haloperidol Haldol 58 Venous thromboembolism 58 coadministration 58 symptomatic hypotension 58 renal denervation 58 bosentan 58 Diovan HCT 58 thyroxine 58 colorectal adenoma 58 inhaled corticosteroids ICS 58 hypercholesterolaemia 58 imatinib therapy 58 Xelox 58 ipsilateral stroke 58 serum PSA 58 H. pylori eradication 58 rosuvastatin 58 carboplatin paclitaxel 58 paliperidone palmitate 58 VIRAMUNE XR 58 hypogonadal men 58 vandetanib 58 anti androgen 58 Aggrastat ® tirofiban hydrochloride 58 PCIs 58 symptomatic paroxysmal AF 58 hemoglobin A1c HbA1c 58 activated partial thromboplastin 58 chest radiographs 58 statin medications 58 XEPLION R 58 nomograms 58 transplantation HCT 58 variceal bleeding 58 dosing interval 58 inotropic agents 58 prospective multicenter study 58 LTRA 58 opioid dependent 58 MACCE 58 esophagectomy 58 Cystectomy 58 sirolimus eluting stents 58 intensive lipid lowering 58 antiplatelet agent 58 inhaled corticosteroids 58 neoadjuvant therapy 58 angiotensin converting enzyme inhibitors 58 PROMACTA 58 Warfarin Coumadin 58 #mg dose [001] 58 LAGB 58 nonvertebral fractures 58 PEGINTRON TM 58 KETEK 58 Coronary Artery Bypass Grafting 58 haematologic 58 Radical prostatectomy 58 pegfilgrastim 58 Tekamlo 58 aspartate aminotransferase AST 58 AVANDIA 58 arteriography 58 posaconazole 58 periodically reassessed 58 muraglitazar 58 prostate TURP 58 colesevelam HCl 58 randomized trials 58 #mg dose [002] 58 peg interferon 58 VELCADE melphalan 58 lipid lowering therapies 58 pioglitazone Actos 58 pulmonary artery catheterization 58 cardiac resynchronization 58 dalteparin 58 PSADT 58 bisoprolol 58 primary percutaneous coronary 58 Revlimid lenalidomide 58 macroalbuminuria 58 overactive bladder symptoms 58 TAXUS VI 58 intima media thickness 58 AZILECT ® 58 enzastaurin 58 concomitant AEDs 58 Hypotension 58 simvastatin ezetimibe 58 5-fluorouracil/leucovorin 58 adrenalectomy 58 PAOD 58 CYPHER ® 58 conjugated equine estrogen 58 serum cortisol 58 Pemetrexed 58 GPIIb IIIa inhibitors 58 aminotransferases 58 recombinant tissue plasminogen 58 glycemia 58 acute coronary syndromes 58 oral corticosteroid 58 pelvic lymph node dissection 58 onset atrial fibrillation 58 fulvestrant 58 concomitant antibiotics 58 cardiovascular morbidity 58 prasugrel Effient 58 anticholinergic drugs 58 intra ocular pressure 58 Candesartan 58 premedication 58 placebo dexamethasone 58 CRT ICD 58 ARB telmisartan 58 postoperative infection 58 hypoglycemic episodes 58 acute coronary syndrome 58 aripiprazole Abilify 58 Fondaparinux 58 duplex ultrasonography 58 ancrod 58 subcutaneous insulin 58 Helicobacter pylori eradication 58 PSA nadir 58 INVEGA SUSTENNA 58 phase IIIb 58 cranial radiation 58 abdominal hysterectomy 58 ALGRX 58 placebo controlled clinical 58 liver biopsy 58 warfarin sodium 58 Acute Ischemic Stroke 58 fluticasone salmeterol 58 antiretroviral regimens 58 BENICAR 58 TREDAPTIVE 58 elevated LDL cholesterol 58 EDARBI 58 calculated creatinine clearance 58 mealtime insulin 58 APTIVUS R 58 herpetic keratitis 58 non metastatic osteosarcoma 58 aerosolized KL4 surfactant 58 antithrombotic agent 58 MitraClip device 58 induce orthostatic hypotension 58 PONV 58 aneurysmal subarachnoid hemorrhage 58 Inhaled nitric oxide 58 palliation 58 transfemoral approach 58 CIMZIA ™ 58 MMRV vaccine 58 androgen deficiency 58 NSTEMI 58 Hormonal therapy 58 abacavir lamivudine 58 thiazide diuretics 58 defibrillator implantation 58 sargramostim 58 hormonal therapy 58 MIRAPEX ER 58 Renal dysfunction 58 ticagrelor 58 mycophenolate mofetil MMF 58 VAPRISOL 58 carotid IMT 58 dosing regimens 58 prospectively defined 58 allogeneic SCT 58 procalcitonin 58 glycosylated hemoglobin levels 58 levodopa carbidopa 58 definite stent thrombosis 58 long acting bronchodilator 58 elevated serum creatinine 58 CTAP# Capsules 58 RISPERDAL ® 58 subcutaneous infusion 57 treatment regimens 57 Q#IR 57 thrombocytopenic patients 57 azacitidine 57 timepoints 57 aortic root replacement 57 neoadjuvant 57 lapatinib Tykerb 57 RSD# oral 57 metformin sulfonylurea 57 resectable 57 temsirolimus 57 droperidol 57 warfarin Coumadin 57 RE LY ® 57 AA Amyloidosis 57 UKPDS 57 Raptiva r 57 neoadjuvant treatment 57 TroVax ® 57 stent implantation 57 AVODART 57 CANCIDAS 57 pulmonary resection 57 anticonvulsant drugs 57 stage IIIB 57 QT interval 57 TURBT 57 oxymorphone ER 57 ziprasidone 57 percutaneous interventions 57 MERLIN TIMI 57 grade cervical intraepithelial 57 secondary efficacy endpoint 57 endoscopic ultrasonography 57 axillary node dissection 57 tumor necrosis 57 salmeterol HFA MDI 57 surgical debulking 57 hepatic resection 57 mg kg dose 57 serum uric acid 57 MAO inhibitors 57 Dasatinib 57 chronic hemodialysis 57 COPAXONE R